{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:14:49Z","timestamp":1789906489374,"version":"4.0.1"},"reference-count":148,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.rdc.2021.07.005","type":"journal-article","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T01:54:52Z","timestamp":1630029292000},"page":"619-641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Uveitis in Children and Adolescents"],"prefix":"10.1016","volume":"47","author":[{"given":"Margaret H.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica G.","family":"Shantha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob J.","family":"Fondriest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy S.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9552-6464","authenticated-orcid":false,"given":"Sheila T.","family":"Angeles-Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9563","key":"10.1016\/j.rdc.2021.07.005_bib1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","article-title":"Juvenile idiopathic arthritis","volume":"369","author":"Ravelli","year":"2007","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.rdc.2021.07.005_bib2","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.ophtha.2009.05.002","article-title":"Epidemiology and course of disease in childhood uveitis","volume":"116","author":"Smith","year":"2009","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.005_bib3","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1167\/iovs.10-6909","article-title":"Understanding autoimmune uveitis through animal models. The Friedenwald Lecture","volume":"52","author":"Caspi","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.005_bib4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00281-019-00758-z","article-title":"Resolution of uveitis","volume":"41","author":"Wildner","year":"2019","journal-title":"Semin Immunopathol"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.005_bib5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nri3391","article-title":"Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates","volume":"13","author":"Shechter","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.005_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1189\/jlb.1102574","article-title":"Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation","volume":"74","author":"Streilein","year":"2003","journal-title":"J\u00a0Leukoc Biol"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.005_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0974-9233.92111","article-title":"Update on sympathetic ophthalmia","volume":"19","author":"Arevalo","year":"2012","journal-title":"Middle East Afr J Ophthalmol"},{"key":"10.1016\/j.rdc.2021.07.005_bib8","doi-asserted-by":"crossref","first-page":"580636","DOI":"10.3389\/fimmu.2020.580636","article-title":"Molecular mimicry and uveitis","volume":"11","author":"Wildner","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.005_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1076\/ocii.6.3.173.4044","article-title":"A\u00a0novel method for the determination of T-cell proliferative responses in patients with uveitis","volume":"6","author":"de Smet","year":"1998","journal-title":"Ocul Immunol Inflamm"},{"issue":"9","key":"10.1016\/j.rdc.2021.07.005_bib10","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1172\/JCI42440","article-title":"A\u00a0look at autoimmunity and inflammation in the eye","volume":"120","author":"Caspi","year":"2010","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.005_bib11","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1167\/iovs.13-13444","article-title":"Correlation between disease severity and presence of ocular autoantibodies in juvenile idiopathic arthritis-associated uveitis","volume":"55","author":"Walscheid","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.rdc.2021.07.005_bib12","first-page":"1074","article-title":"Antibodies to iris and retina detected in sera from patients with juvenile rheumatoid arthritis with iridocyclitis by indirect immunofluorescence studies on human eye tissue","volume":"16","author":"Uchiyama","year":"1989","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2021.07.005_bib13","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3389\/fimmu.2019.01793","article-title":"Identification of ocular autoantigens associated with juvenile idiopathic arthritis-associated uveitis","volume":"10","author":"Busch","year":"2019","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.005_bib14","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/archopht.1983.01040020087015","article-title":"Early-onset pauciarticular juvenile rheumatoid arthritis. A histopathologic study","volume":"101","author":"Merriam","year":"1983","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.rdc.2021.07.005_bib15","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1167\/iovs.15-17351","article-title":"Infiltration of plasma cells in the iris of children with ANA-positive anterior uveitis","volume":"56","author":"Kalinina Ayuso","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.rdc.2021.07.005_bib16","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.ophtha.2008.03.027","article-title":"Immunohistochemical study of chronic nongranulomatous anterior uveitis in juvenile idiopathic arthritis","volume":"115","author":"Parikh","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.rdc.2021.07.005_bib17","doi-asserted-by":"crossref","first-page":"107853","DOI":"10.1016\/j.exer.2019.107853","article-title":"Uveitis genetics","volume":"190","author":"Hou","year":"2020","journal-title":"Exp Eye Res"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.005_bib18","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1186\/ar4293","article-title":"TNF receptor-associated factor 5 gene confers genetic predisposition to acute anterior uveitis and pediatric uveitis","volume":"15","author":"Xiang","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.005_bib19","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/art.38409","article-title":"Epigenome-wide scan identifies a treatment-responsive pattern of altered DNA methylation among cytoskeletal remodeling genes in monocytes and CD4+ T\u00a0cells from patients with Behcet's disease","volume":"66","author":"Hughes","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rdc.2021.07.005_bib20","doi-asserted-by":"crossref","first-page":"20057","DOI":"10.1038\/srep20057","article-title":"miR-23a, miR-146a and miR-301a confer predisposition to Vogt-Koyanagi-Harada syndrome but not to Behcet's disease","volume":"6","author":"Hou","year":"2016","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.005_bib21","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/art.39621","article-title":"Ocular fluid analysis in children reveals interleukin-29\/interferon-lambda1 as a biomarker for juvenile idiopathic arthritis-associated uveitis","volume":"68","author":"Haasnoot","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"13","key":"10.1016\/j.rdc.2021.07.005_bib22","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1167\/iovs.15-17066","article-title":"Elevated S100A8\/A9 and S100A12 serum levels reflect intraocular inflammation in juvenile idiopathic arthritis-associated uveitis: results from a pilot study","volume":"56","author":"Walscheid","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.005_bib23","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1167\/iovs.12-10865","article-title":"Intraocular biomarker identification in uveitis associated with juvenile idiopathic arthritis","volume":"54","author":"Kalinina Ayuso","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.005_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/09273940802409969","article-title":"Distinct cytokine patterns in the aqueous humor of children, adolescents and adults with uveitis","volume":"16","author":"Sijssens","year":"2008","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.005_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.exer.2007.06.011","article-title":"Cytokines, chemokines and soluble adhesion molecules in aqueous humor of children with uveitis","volume":"85","author":"Sijssens","year":"2007","journal-title":"Exp Eye Res"},{"issue":"10","key":"10.1016\/j.rdc.2021.07.005_bib26","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/art.40544","article-title":"Risk factors and biomarkers for the occurrence of uveitis in juvenile idiopathic arthritis: data from the inception cohort of newly diagnosed patients with juvenile idiopathic arthritis study","volume":"70","author":"Tappeiner","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.005_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12348-018-0156-5","article-title":"Discovery of tear biomarkers in children with chronic non-infectious anterior uveitis: a pilot study","volume":"8","author":"Angeles-Han","year":"2018","journal-title":"J\u00a0Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.rdc.2021.07.005_bib28","first-page":"1","article-title":"S100 proteins, cytokines, and chemokines as tear biomarkers in children with juvenile idiopathic arthritis-associated uveitis","author":"Angeles-Han","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.005_bib29","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1111\/aos.13292","article-title":"Cytokine and chemokine tear levels in patients with uveitis","volume":"95","author":"Carreno","year":"2017","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"10.1016\/j.rdc.2021.07.005_bib30","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00417-020-04707-7","article-title":"Tear cytokines as potential biomarkers in non-infectious uveitis: post hoc analysis of a randomised clinical trial","volume":"258","author":"Shirinsky","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.005_bib31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00055735-200312000-00013","article-title":"Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis","volume":"14","author":"Foster","year":"2003","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.005_bib32","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ajo.2008.11.009","article-title":"Chronic anterior uveitis in children: clinical characteristics and complications","volume":"147","author":"Holland","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.rdc.2021.07.005_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12969-015-0018-8","article-title":"Characteristics of a cohort of children with juvenile idiopathic arthritis and JIA-associated uveitis","volume":"13","author":"Angeles-Han","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.005_bib34","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ajo.2007.01.033","article-title":"Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss","volume":"143","author":"Thorne","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.005_bib35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1542\/peds.92.2.295","article-title":"American Academy of Pediatrics Section on Rheumatology and Section on Ophthalmology: guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis","volume":"92","year":"1993","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.005_bib36","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/rheumatology\/kem053","article-title":"Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines","volume":"46","author":"Heiligenhaus","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.005_bib37","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/art.40885","article-title":"2019 American College of Rheumatology\/Arthritis Foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis","volume":"71","author":"Angeles-Han","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2021.07.005_bib38","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/annrheumdis-2018-213131","article-title":"Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative","volume":"77","author":"Constantin","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2021.07.005_bib39","unstructured":"Angeles-Han ST, Imundo L, Lo MS, et\u00a0al. Screening for early detection of ocular disorders in two populations: children with juvenile idiopathic arthritis and children being treated with hydroxychloroquine. Pediatrics, in press."},{"issue":"12","key":"10.1016\/j.rdc.2021.07.005_bib40","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3899\/jrheum.130302","article-title":"Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry","volume":"40","author":"Angeles-Han","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.005_bib41","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.ophtha.2005.01.044","article-title":"Analysis of pediatric uveitis cases at a tertiary referral center","volume":"112","author":"Kump","year":"2005","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.005_bib42","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/112067210301300704","article-title":"Prognosis of juvenile rheumatoid arthritis-associated uveitis","volume":"13","author":"Paroli","year":"2003","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.005_bib43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/09273940590909220","article-title":"Visual outcome of juvenile rheumatoid arthritis-associated uveitis in adults","volume":"13","author":"Ozdal","year":"2005","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.005_bib44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.005_bib45","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4103\/2008-322X.176897","article-title":"Pars planitis: epidemiology, clinical characteristics, management and visual prognosis","volume":"10","author":"Ozdal","year":"2015","journal-title":"J\u00a0Ophthalmic Vis Res"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.005_bib46","first-page":"259","article-title":"Pediatric uveitis","volume":"6","author":"Tugal-Tutkun","year":"2011","journal-title":"J\u00a0Ophthalmic Vis Res"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.005_bib47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0002-9394(14)70994-8","article-title":"The association of HLA-DR15 and intermediate uveitis","volume":"123","author":"Tang","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.005_bib48","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0161-6420(93)31567-8","article-title":"Long-term visual outcome and complications associated with pars planitis","volume":"100","author":"Malinowski","year":"1993","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.005_bib49","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/bjo.2010.184267","article-title":"Young age as a risk factor for complicated course and visual outcome in intermediate uveitis in children","volume":"95","author":"Kalinina Ayuso","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.rdc.2021.07.005_bib50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajo.2015.12.034","article-title":"Remission of intermediate uveitis: incidence and predictive factors","volume":"164","author":"Kempen","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.rdc.2021.07.005_bib51","series-title":"Diagnosis & treatment of uveitis","author":"Foster","year":"2013"},{"key":"10.1016\/j.rdc.2021.07.005_bib52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1546-0096-11-16","article-title":"Superior efficacy of adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis","volume":"11","author":"Simonini","year":"2013","journal-title":"Pediatr Rheumatol Online J"},{"issue":"9","key":"10.1016\/j.rdc.2021.07.005_bib53","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/bjo.87.9.1175","article-title":"Behcet's disease: from Hippocrates to the third millennium","volume":"87","author":"Verity","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.005_bib54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/09273948.2011.555592","article-title":"Behcet disease in children","volume":"19","author":"Atmaca","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.005_bib55","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jaad.2007.10.452","article-title":"Demographic and clinical properties of juvenile-onset Behcet's disease: a controlled multicenter study","volume":"58","author":"Karincaoglu","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.005_bib56","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0002-9394(03)00791-8","article-title":"Childhood-onset uveitis in Behcet disease: a descriptive study of 36 cases","volume":"136","author":"Tugal-Tutkun","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.005_bib57","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/ard.43.6.783","article-title":"Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome","volume":"43","author":"Yazici","year":"1984","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.005_bib58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","article-title":"Uveitis in Behcet disease: an analysis of 880 patients","volume":"138","author":"Tugal-Tutkun","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.005_bib59","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajo.2014.10.013","article-title":"Uveitis in Behcet disease in a tertiary center over 25 years: the KKESH Uveitis Survey Study Group","volume":"159","author":"Arevalo","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.005_bib60","first-page":"373","article-title":"Blau syndrome mutation of CARD15\/NOD2 in sporadic early onset granulomatous arthritis","volume":"32","author":"Rose","year":"2005","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.005_bib61","doi-asserted-by":"crossref","first-page":"e000097","DOI":"10.1136\/rmdopen-2015-000097","article-title":"Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease","volume":"1","author":"Caso","year":"2015","journal-title":"RMD Open"},{"key":"10.1016\/j.rdc.2021.07.005_bib62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1546-0096-12-33","article-title":"Blau syndrome, the prototypic auto-inflammatory granulomatous disease","volume":"12","author":"Wouters","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.005_bib63","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11926-005-0046-3","article-title":"Blau syndrome and related genetic disorders causing childhood arthritis","volume":"7","author":"Becker","year":"2005","journal-title":"Curr Rheumatol Rep"},{"issue":"10","key":"10.1016\/j.rdc.2021.07.005_bib64","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/art.22122","article-title":"Pediatric granulomatous arthritis: an international registry","volume":"54","author":"Rose","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.005_bib65","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archophthalmol.2011.52","article-title":"Clinical features and diagnostic evaluation of biopsy-proven ocular sarcoidosis","volume":"129","author":"Birnbaum","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.005_bib66","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10384-006-0413-2","article-title":"Evaluation of characteristic ocular signs and systemic investigations in ocular sarcoidosis patients","volume":"51","author":"Kawaguchi","year":"2007","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.005_bib67","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/09273940902818861","article-title":"International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS)","volume":"17","author":"Herbort","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.005_bib68","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/09273948.2014.939530","article-title":"Vogt-Koyanagi-Harada disease","volume":"22","author":"Cunningham","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.005_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2016.05.002","article-title":"Vogt-Koyanagi-Harada disease","volume":"62","author":"O'Keefe","year":"2017","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.005_bib70","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/archopht.1991.01080050096037","article-title":"Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome","volume":"109","author":"Rubsamen","year":"1991","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.005_bib71","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0039-6257(05)80105-5","article-title":"Vogt-Koyanagi-Harada syndrome","volume":"39","author":"Moorthy","year":"1995","journal-title":"Surv Ophthalmol"},{"issue":"4\u20135","key":"10.1016\/j.rdc.2021.07.005_bib72","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.autrev.2014.01.023","article-title":"Diagnosis and classification of Vogt-Koyanagi-Harada disease","volume":"13","author":"Sakata","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.005_bib73","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bjo.2008.148015","article-title":"Uveitis survey in children","volume":"93","author":"Hamade","year":"2009","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.005_bib74","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/IAE.0b013e3181c96a87","article-title":"Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India","volume":"30","author":"Martin","year":"2010","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.005_bib75","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","article-title":"Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature","volume":"131","author":"Read","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.005_bib76","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jfo.2019.10.005","article-title":"Clinical and therapeutic features of pediatric Vogt-Koyanagi-Harada disease","volume":"43","author":"Albaroudi","year":"2020","journal-title":"J\u00a0Fr Ophtalmol"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.005_bib77","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ajo.2005.04.019","article-title":"Clinical features in tubulointerstitial nephritis and uveitis (TINU) syndrome","volume":"140","author":"Goda","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.005_bib78","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0039-6257(01)00261-2","article-title":"The tubulointerstitial nephritis and uveitis syndrome","volume":"46","author":"Mandeville","year":"2001","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.005_bib79","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ophtha.2007.01.002","article-title":"Enhanced recognition, treatment, and prognosis of tubulointerstitial nephritis and uveitis syndrome","volume":"114","author":"Mackensen","year":"2007","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.005_bib80","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/09273948.2017.1420202","article-title":"The challenge of pediatric uveitis: tertiary referral center experience in the United States","volume":"27","author":"Ferrara","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"10.1016\/j.rdc.2021.07.005_bib81","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.ophtha.2004.06.014","article-title":"Ocular complications of pediatric uveitis","volume":"111","author":"Rosenberg","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.rdc.2021.07.005_bib82","article-title":"Clinical features of paediatric uveitis at a tertiary referral centre in Sao Paulo, SP, Brazil","author":"Souto","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.005_bib83","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3928\/0191-3913-19690801-09","article-title":"Uveitis in children\u2217: a follow-up study","volume":"6","author":"Makley","year":"1969","journal-title":"J\u00a0Pediatr Ophthalmol Strabismus"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.005_bib84","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/09273949709116894","article-title":"Pediatric uveitis in southern Turkey","volume":"5","author":"Soylu","year":"1997","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.005_bib85","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1034\/j.1600-0420.2000.078001084.x","article-title":"Uveitis in children: population-based study in Finland","volume":"78","author":"Paivonsalo-Hietanen","year":"2000","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.rdc.2021.07.005_bib86","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.actatropica.2016.02.013","article-title":"Evaluation of the Goldmann-Witmer coefficient in the immunological diagnosis of ocular toxocariasis","volume":"158","author":"Wang","year":"2016","journal-title":"Acta Trop"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.005_bib87","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10792-015-0134-y","article-title":"Two masquerade presentations of retinoblastoma","volume":"36","author":"Lembo","year":"2016","journal-title":"Int Ophthalmol"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.005_bib88","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/rheumatology\/key406","article-title":"Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study","volume":"58","author":"Heiligenhaus","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.005_bib89","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/09273940802650398","article-title":"Long-term follow-up of patients with uveitis associated with juvenile idiopathic arthritis: a cohort study","volume":"17","author":"Skarin","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.rdc.2021.07.005_bib90","series-title":"Basic and clinical science course 2020-2021","author":"Ophthalmology AAo","year":"2020"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.005_bib91","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12969-016-0069-5","article-title":"Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry","volume":"14","author":"Henderson","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.005_bib92","first-page":"539","article-title":"Course, complications, and outcome of juvenile arthritis-related uveitis","volume":"12","author":"Sabri","year":"2008","journal-title":"J\u00a0AAPOS"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.005_bib93","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2012.07.052","article-title":"Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the systemic immunosuppressive therapy for eye diseases study","volume":"120","author":"Gregory","year":"2013","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.005_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IIO.0b013e3181695b80","article-title":"Cataract surgery in children with juvenile idiopathic arthritis associated uveitis","volume":"48","author":"Acevedo","year":"2008","journal-title":"Int Ophthalmol Clin"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.005_bib95","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1755-3768.2011.02110.x","article-title":"Favourable outcome after cataract surgery with IOL implantation in uveitis associated with juvenile idiopathic arthritis","volume":"90","author":"Grajewski","year":"2012","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.005_bib96","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/ICU.0b013e32831b9b22","article-title":"Cataract surgery in the setting of uveitis","volume":"20","author":"Van Gelder","year":"2009","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.005_bib97","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/art.41530","article-title":"Imaging-based uveitis surveillance in juvenile idiopathic arthritis: feasibility, acceptability, and diagnostic performance","volume":"73","author":"Akbarali","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.005_bib98","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ophtha.2015.02.032","article-title":"Automated analysis of anterior chamber inflammation by spectral-domain optical coherence tomography","volume":"122","author":"Sharma","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.rdc.2021.07.005_bib99","first-page":"1","article-title":"Anterior segment inflammation in pediatric uveitis is associated with reduced retinal vascular density as quantified by optical coherence tomography angiography","author":"Qu","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.005_bib100","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00296-015-3231-3","article-title":"Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus","volume":"35","author":"Bou","year":"2015","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.005_bib101","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00296-011-2126-1","article-title":"Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis","volume":"32","author":"Heiligenhaus","year":"2012","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.005_bib102","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/acr.23871","article-title":"2019 American College of Rheumatology\/Arthritis Foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis","volume":"71","author":"Angeles-Han","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.rdc.2021.07.005_bib103","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajo.2019.02.011","article-title":"Visual and clinical outcome of macular edema complicating pediatric noninfectious uveitis","volume":"202","author":"Eiger-Moscovich","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.005_bib104","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/BOR.0000000000000723","article-title":"Update on noninfectious uveitis in children and its treatment","volume":"32","author":"Maccora","year":"2020","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.005_bib105","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ophtha.2009.12.003","article-title":"Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids","volume":"117","author":"Thorne","year":"2010","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.005_bib106","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ophtha.2018.08.021","article-title":"Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone implant for the treatment of uveitic macular edema: the PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial","volume":"126","author":"Thorne","year":"2019","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.005_bib107","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/acr.23610","article-title":"Childhood arthritis and rheumatology research alliance consensus treatment plans for juvenile idiopathic arthritis-associated and idiopathic chronic anterior uveitis","volume":"71","author":"Angeles-Han","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.005_bib108","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0022-3476(98)70232-X","article-title":"Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis","volume":"133","author":"Weiss","year":"1998","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.005_bib109","first-page":"362","article-title":"Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis","volume":"32","author":"Foeldvari","year":"2005","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2021.07.005_bib110","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ophtha.2009.04.020","article-title":"Methotrexate for ocular inflammatory diseases","volume":"116","author":"Gangaputra","year":"2009","journal-title":"Ophthalmology"},{"issue":"17","key":"10.1016\/j.rdc.2021.07.005_bib111","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","article-title":"Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis","volume":"376","author":"Ramanan","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.005_bib112","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/annrheumdis-2017-212089","article-title":"ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis","volume":"77","author":"Quartier","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.005_bib113","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/rheumatology\/kez449","article-title":"The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data","volume":"59","author":"Davies","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.rdc.2021.07.005_bib114","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/acr.22613","article-title":"Uveitis events during adalimumab, etanercept, and methotrexate therapy in juvenile idiopathic arthritis: data from the biologics in pediatric rheumatology registry","volume":"67","author":"Foeldvari","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.005_bib115","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/ard.2006.058248","article-title":"Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis","volume":"66","author":"Tynjala","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.005_bib116","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/acr.20404","article-title":"Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab","volume":"63","author":"Simonini","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"10.1016\/j.rdc.2021.07.005_bib117","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3899\/jrheum.171006","article-title":"Longterm safety and efficacy of adalimumab and infliximab for uveitis associated with juvenile idiopathic arthritis","volume":"45","author":"Cecchin","year":"2018","journal-title":"J\u00a0Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2021.07.005_bib118","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1002\/art.41026","article-title":"Comparative study of infliximab versus adalimumab in refractory uveitis due to Behcet's disease: National Multicenter Study of 177 cases","volume":"71","author":"Atienza-Mateo","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rdc.2021.07.005_bib119","doi-asserted-by":"crossref","first-page":"765380","DOI":"10.5402\/2012\/765380","article-title":"High dose infliximab in the treatment of refractory uveitis: does dose matter?","volume":"2012","author":"Sukumaran","year":"2012","journal-title":"ISRN Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.005_bib120","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.berh.2018.01.002","article-title":"Juvenile idiopathic arthritis-associated uveitis","volume":"31","author":"Sen","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.005_bib121","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/jcpt.12821","article-title":"Tocilizumab for refractory uveitis associated with juvenile idiopathic arthritis: a report of two cases","volume":"44","author":"Dipasquale","year":"2019","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.rdc.2021.07.005_bib122","first-page":"1","article-title":"Tocilizumab employment in the treatment of resistant juvenile idiopathic arthritis associated uveitis","author":"Maleki","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"4 Suppl 84","key":"10.1016\/j.rdc.2021.07.005_bib123","first-page":"S75","article-title":"Tocilizumab in severe and refractory non-infectious uveitis","volume":"32","author":"Papo","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.005_bib124","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/S2665-9913(20)30008-4","article-title":"Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial","volume":"2","author":"Ramanan","year":"2020","journal-title":"Lancet Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2021.07.005_bib125","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00417-015-3140-x","article-title":"Long-term efficacy of abatacept in pediatric patients with idiopathic uveitis: a case series","volume":"253","author":"Marrani","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.005_bib126","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/acr.20115","article-title":"Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis","volume":"62","author":"Zulian","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.005_bib127","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3899\/jrheum.140410","article-title":"Abatacept in the treatment of severe, longstanding, and refractory uveitis associated with juvenile idiopathic arthritis","volume":"42","author":"Tappeiner","year":"2015","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2021.07.005_bib128","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.3899\/jrheum.151389","article-title":"Comparable efficacy of abatacept used as first-line or second-line biological agent for severe juvenile idiopathic arthritis-related uveitis","volume":"43","author":"Birolo","year":"2016","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.005_bib129","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1756-185X.2010.01546.x","article-title":"Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study)","volume":"13","author":"Davatchi","year":"2010","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.005_bib130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/IAE.0000000000001563","article-title":"Long-term outcomes of rituximab therapy in patients with noninfectious posterior uveitis refractory to conventional immunosuppressive therapy","volume":"38","author":"Lasave","year":"2018","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.005_bib131","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/14397595.2015.1071234","article-title":"Rituximab for sight-threatening refractory pediatric Vogt-Koyanagi-Harada disease","volume":"28","author":"Umran","year":"2018","journal-title":"Mod Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.005_bib132","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/bjophthalmol-2015-306790","article-title":"Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis","volume":"100","author":"Miserocchi","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.005_bib133","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10067-019-04875-w","article-title":"JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis","volume":"39","author":"Miserocchi","year":"2020","journal-title":"Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2021.07.005_bib134","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/09273948.2019.1605453","article-title":"Effect of Janus kinase inhibitor treatment on anterior uveitis and associated macular edema in an adult patient with juvenile idiopathic arthritis","volume":"27","author":"Bauermann","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.005_bib135","first-page":"18","article-title":"Relaxation methods in the control of essential hypertension","volume":"18","author":"Henry","year":"1987","journal-title":"J\u00a0N Y State Nurses Assoc"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.005_bib136","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/bjo.2009.168856","article-title":"Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment","volume":"95","author":"Yamada","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.005_bib137","doi-asserted-by":"crossref","first-page":"e9118","DOI":"10.1590\/1414-431x20209118","article-title":"Evaluation of factors for predicting risk of uveitis recurrence in Behcet's disease patients","volume":"53","author":"Cai","year":"2020","journal-title":"Braz J Med Biol Res"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.005_bib138","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s10792-020-01647-3","article-title":"Vogt-Koyanagi-Harada disease in a native American population in Oklahoma","volume":"41","author":"Reddy","year":"2021","journal-title":"Int Ophthalmol"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.005_bib139","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12886-020-01656-x","article-title":"Vogt-Koyanagi-Harada disease: a retrospective and multicentric study of 41 patients","volume":"20","author":"Diallo","year":"2020","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.005_bib140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1076\/ocii.6.3.155.4041","article-title":"Vogt-Koyanagi-Harada syndrome in children","volume":"6","author":"Rathinam","year":"1998","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.005_bib141","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s40272-019-00362-6","article-title":"Treatment withdrawal following remission in juvenile idiopathic arthritis: a systematic review of the literature","volume":"21","author":"Halyabar","year":"2019","journal-title":"Paediatr Drugs"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.005_bib142","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1080\/09273948.2018.1424341","article-title":"Relapse of juvenile idiopathic arthritis-associated uveitis after discontinuation of immunomodulatory therapy","volume":"27","author":"Acharya","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.005_bib143","first-page":"460","article-title":"Risk factors associated with the relapse of uveitis in patients with juvenile idiopathic arthritis: a preliminary report","volume":"17","author":"Saboo","year":"2013","journal-title":"J\u00a0AAPOS"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.005_bib144","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3899\/jrheum.161336","article-title":"Predictors of relapse after discontinuing systemic treatment in childhood autoimmune chronic uveitis","volume":"44","author":"Simonini","year":"2017","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.005_bib145","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/09273948.2013.812222","article-title":"Recurrence of uveitis after discontinuation of infliximab","volume":"22","author":"Shakoor","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.005_bib146","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajo.2015.04.016","article-title":"Uveitis reactivation in children treated with tumor necrosis factor alpha inhibitors","volume":"160","author":"Lerman","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.005_bib147","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ajo.2010.08.021","article-title":"Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis","volume":"151","author":"Kalinina Ayuso","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"13","key":"10.1016\/j.rdc.2021.07.005_bib148","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2010.375","article-title":"Methotrexate withdrawal at 6 vs 12\u00a0months in juvenile idiopathic arthritis in remission: a randomized clinical trial","volume":"303","author":"Foell","year":"2010","journal-title":"JAMA"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X21010991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X21010991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:21:17Z","timestamp":1760181677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X21010991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":148,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0889857X21010991"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2021.07.005","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uveitis in Children and Adolescents","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2021.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}